세계의 글루카곤 딜리버리 디바이스 시장 : 유형별, 유통 채널별, 용도별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Glucagon Delivery Devices Market size was valued at USD 2,150.42 million in 2023, expanding at a CAGR of 8.72% from 2024 to 2032.

The Glucagon Delivery Devices Market is experiencing significant growth due to the increasing prevalence of diabetes and the rising demand for efficient glucose management solutions. Glucagon delivery devices are used to administer glucagon, a hormone that raises blood glucose levels, in emergencies such as severe hypoglycemia. The market is bolstered by technological advancements, including the development of more user-friendly and precise delivery systems. For instance, a recent survey indicated that over 70% of endocrinologists prefer devices with automated features to ensure accurate dosing. However, the market faces challenges such as the high cost of advanced devices and the need for patient education on proper usage. Opportunities exist to expand personalized and connected glucagon delivery systems that integrate with digital health platforms. For example, the integration of smart technology into glucagon delivery devices is expected to enhance patient compliance and overall diabetes management.

Glucagon Delivery Devices Market- Market Dynamics

Rising Diabetes Prevalence Drives Demand for Glucagon Delivery Devices

The surge in diabetes prevalence is significantly boosting the demand for glucagon-delivery devices. According to the International Diabetes Federation, over 450 million people worldwide are living with diabetes, creating a substantial need for effective emergency treatments like glucagon. For instance, the American Diabetes Association reports that severe hypoglycemic episodes, which require glucagon administration, affect a significant portion of diabetic patients, particularly those with type 1 diabetes. In response, companies such as Eli Lilly are expanding their product lines and improving device technology to meet the growing demand. Additionally, health initiatives in the U.S. and Europe are emphasizing better diabetes management solutions, further accelerating the adoption of advanced glucagon delivery devices. These efforts highlight the critical role of glucagon devices in managing diabetes-related emergencies and ensuring better patient outcomes.

Glucagon Delivery Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.72% over the forecast period (2024-2032)

Based on Type segmentation, Auto-Injectors were predicted to show maximum market share in the year 2023

Based on Distribution Channel segmentation, Retail Pharmacies were the leading type in 2023

Based on Application segmentation, Emergency Kits was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Glucagon Delivery Devices Market- Segmentation Analysis:

The Global Glucagon Delivery Devices Market is segmented on the basis of Type, Distribution Channel, Application, End-User, and Region.

The market is divided into four categories based on Type: Prefilled Syringes, Auto-Injectors, Nasal Sprays, and Needle-Free Injectors. Auto-injectors hold the highest priority due to their ease of use and effectiveness in emergencies. Prefilled Syringes follow, valued for their convenience. Nasal Sprays are gaining traction, while Needle-Free Injectors are niche but growing.

The market is divided into three categories based on Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Retail Pharmacies lead due to their widespread accessibility and patient familiarity. Hospital Pharmacies follow, catering to in-hospital needs and emergency situations. Online Pharmacies are growing, offering convenience and a broad selection for home use.

Glucagon Delivery Devices Market- Geographical Insights

The Glucagon Delivery Devices Market shows varied regional dynamics, with North America leading due to high diabetes prevalence and advanced healthcare infrastructure. In the U.S., over 30 million people have diabetes, driving demand for effective glucagon delivery solutions. The American Diabetes Association's initiatives, such as the promotion of better management tools, further bolster market growth. Europe follows, with countries like Germany and the U.K. investing in advanced diabetes care technologies. Germany's recent funding for diabetes research and development highlights the region's commitment to improving glucagon delivery devices. The Asia-Pacific region, notably China and India, is emerging rapidly due to increasing diabetes rates and rising healthcare investments. For instance, China's national health initiatives are focusing on enhancing diabetes management infrastructure, which is expanding the market for glucagon delivery devices. These regional efforts reflect a growing global focus on improving diabetes care and emergency treatment options.

Glucagon Delivery Devices Market- Competitive Landscape:

The Glucagon Delivery Devices Market is highly competitive, with major players such as Eli Lilly and Company, Novo Nordisk, and Sanofi at the forefront. Eli Lilly, for example, has been expanding its market presence through strategic collaborations; in 2022, the company partnered with Dexcom to integrate glucagon delivery with continuous glucose monitoring systems, enhancing the effectiveness of diabetes management. Novo Nordisk has also strengthened its position by acquiring the diabetes technology company, Glooko, in 2021, aiming to leverage Glooko's digital health solutions to complement its glucagon delivery devices. Sanofi, a key competitor, has been active in research and development, focusing on improving the ease of use and reliability of its glucagon auto-injectors. These strategic initiatives and collaborations reflect the players' commitment to advancing glucagon delivery technologies and meeting the growing demands of diabetes care.

Recent Developments:

In September 2019, Xeris Pharmaceuticals received FDA approval for G-Voke, the first ready-to-use, room-temperature stable liquid glucagon for severe hypoglycemia in diabetes patients aged 2 and above. G-Voke offers a simpler, faster alternative to traditional glucagon emergency kits.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GLUCAGON DELIVERY DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Amphastar Pharmaceuticals, Inc.
• Baxter International Inc.
• Becton, Dickinson and Company
• Eli Lilly and Company
• Fresenius Kabi AG
• GlaxoSmithKline plc
• Kaleo, Inc.
• Medtronic plc
• Novo Nordisk A/S
• Pfizer Inc.
• Sandoz International GmbH
• Sanofi S.A.
• Wockhardt Limited
• Xeris Pharmaceuticals, Inc.
• Ypsomed AG
• Zealand Pharma A/S
• Others

GLOBAL GLUCAGON DELIVERY DEVICES MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

• Prefilled Syringes
• Auto-Injectors
• Nasal Sprays
• Needle-Free Injectors

GLOBAL GLUCAGON DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

GLOBAL GLUCAGON DELIVERY DEVICES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Emergency Kits
• Diabetic Patients
• Diagnostic Testing

GLOBAL GLUCAGON DELIVERY DEVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

• Hospitals
• Clinics
• Homecare Settings
• Emergency Medical Services

GLOBAL GLUCAGON DELIVERY DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Glucagon Delivery Devices Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Glucagon Delivery Devices Market Snippet by Type
  • 2.1.2. Glucagon Delivery Devices Market Snippet by Distribution Channel
  • 2.1.3. Glucagon Delivery Devices Market Snippet by Application
  • 2.1.4. Glucagon Delivery Devices Market Snippet by End-User
  • 2.1.5. Glucagon Delivery Devices Market Snippet by Country
  • 2.1.6. Glucagon Delivery Devices Market Snippet by Region
• 2.2. Competitive Insights

3. Glucagon Delivery Devices Key Market Trends

• 3.1. Glucagon Delivery Devices Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Glucagon Delivery Devices Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Glucagon Delivery Devices Market Opportunities
• 3.4. Glucagon Delivery Devices Market Future Trends

4. Glucagon Delivery Devices Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Glucagon Delivery Devices Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Glucagon Delivery Devices Market Landscape

• 6.1. Glucagon Delivery Devices Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Glucagon Delivery Devices Market - By Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
  • 7.1.2. Prefilled Syringes
  • 7.1.3. Auto-Injectors
  • 7.1.4. Nasal Sprays
  • 7.1.5. Needle-Free Injectors

8. Glucagon Delivery Devices Market - By Distribution Channel

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
  • 8.1.2. Hospital Pharmacies
  • 8.1.3. Retail Pharmacies
  • 8.1.4. Online Pharmacies

9. Glucagon Delivery Devices Market - By Application

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 9.1.2. Emergency Kits
  • 9.1.3. Diabetic Patients
  • 9.1.4. Diagnostic Testing

10. Glucagon Delivery Devices Market - By End-User

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
  • 10.1.2. Hospitals
  • 10.1.3. Clinics
  • 10.1.4. Homecare Settings
  • 10.1.5. Emergency Medical Services

11. Glucagon Delivery Devices Market- By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. Glucagon Delivery Devices Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. Glucagon Delivery Devices Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.9. Italy
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.9.4. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.10. United Kingdom
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.10.4. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.11. France
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.11.4. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.12. Russia
    • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.12.3. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.13. Netherlands
    • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.13.3. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.15. Poland
    • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.15.3. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.16. Rest of Europe
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. Glucagon Delivery Devices Key Manufacturers in Asia Pacific
  • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 11.4.5. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.8. India
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.8.4. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.9. China
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.9.4. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.13. Thailand
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.13.4. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.14. Indonesia
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.14.4. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.16. Rest of APAC
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.16.4. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 11.5. Latin America
  • 11.5.1. Overview
  • 11.5.2. Glucagon Delivery Devices Key Manufacturers in Latin America
  • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 11.5.5. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 11.6. Middle East and Africa
  • 11.6.1. Overview
  • 11.6.2. Glucagon Delivery Devices Key Manufacturers in Middle East and Africa
  • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 11.6.5. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.14. Rest of MEA
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.14.4. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Glucagon Delivery Devices Industry

• 12.1. Competitive Dashboard
• 12.2. Company Profiles
  • 12.2.1. Amphastar Pharmaceuticals, Inc.
  • 12.2.2. Baxter International Inc.
  • 12.2.3. Becton, Dickinson and Company
  • 12.2.4. Eli Lilly and Company
  • 12.2.5. Fresenius Kabi AG
  • 12.2.6. GlaxoSmithKline plc
  • 12.2.7. Kaleo, Inc.
  • 12.2.8. Medtronic plc
  • 12.2.9. Novo Nordisk A/S
  • 12.2.10. Pfizer Inc.
  • 12.2.11. Sandoz International GmbH
  • 12.2.12. Sanofi S.A.
  • 12.2.13. Wockhardt Limited
  • 12.2.14. Xeris Pharmaceuticals, Inc.
  • 12.2.15. Ypsomed AG
  • 12.2.16. Zealand Pharma A/S
  • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us